Follow us:
NEW ARTICLE - Comparison of mAb single-use DSP processes by Sanofi using Ypso-Proxima
EASY: a disruptive mAb purification process to reduce cost of goods
This article [1] illustrates how Ypso-Proxima allows a rational comparison between two biopharmaceutical DSP processes. The innovative EASY mAb purification process developed by Sanofi is matched against the standard proteinA-based DSP counterpart. Relying on Proxima's process evaluation, the...
UP-COMING WEBINAR - Manufacturing in the industry 4.0 era: how to balance innovation with performance while not being disrupted
10th March, with C. Varsakelis (Janssen), Mark Demesmaeker (Sartorius) and RM Nicoud (Ypso-Facto)
FREE webinar! Save your seat now by registering online, here .
NEW ARTICLE – Fareva and Ypso-Facto investigate the purification of an antibiotic by ion-exchange
Using Mechanistic Modeling for Understanding Antibiotics Purification with Ion Exchange Chromatography
This article is based on a real industrial purification process by Fareva and highlights the power of mechanistic modeling for process development: Our client needed to change a raw material to secure his supply chain. From a process point of view, it was supposed to be seamless. However, a...
Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.
Download
© Ypso-Facto 2014 - Powered by Ealys | Legal Information